241 related articles for article (PubMed ID: 34242487)
41. Evaluation of the Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes in China.
Cai MT; Qiao S; Lai QL; Zheng Y; Yang F; Fang GL; Shen CH; Zhang YX; Ding MP
Front Immunol; 2022; 13():790400. PubMed ID: 35173717
[TBL] [Abstract][Full Text] [Related]
42. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients.
Gultekin SH; Rosenfeld MR; Voltz R; Eichen J; Posner JB; Dalmau J
Brain; 2000 Jul; 123 ( Pt 7)():1481-94. PubMed ID: 10869059
[TBL] [Abstract][Full Text] [Related]
43. Whole-body computed tomography as first-line imaging procedure to exclude cancer in patients with neurological suspicion of paraneoplastic syndromes: shall clinical practice adhere to recommendations?
Parillo M; Quattrocchi CC; Pilato F; Di Lazzaro V; Beomonte Zobel B
Radiography (Lond); 2023 Jan; 29(1):8-13. PubMed ID: 36179410
[TBL] [Abstract][Full Text] [Related]
44. FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes.
Younes-Mhenni S; Janier MF; Cinotti L; Antoine JC; Tronc F; Cottin V; Ternamian PJ; Trouillas P; Honnorat J
Brain; 2004 Oct; 127(Pt 10):2331-8. PubMed ID: 15361417
[TBL] [Abstract][Full Text] [Related]
45. [Following sensory neuropathy, anti-Hu antibody-positive paraneoplastic neurological syndrome presenting with limbic encephalitis occurs after complete remission].
Fukami Y; Umemura T; Shimono T; Yokoi T; Kamijo M; Sakakibara T
Rinsho Shinkeigaku; 2013; 53(4):287-92. PubMed ID: 23603543
[TBL] [Abstract][Full Text] [Related]
46. Paraneoplastic autoimmunity and small-cell lung cancer: Neurological and serological accompaniments.
Zekeridou A; Majed M; Heliopoulos I; Lennon VA
Thorac Cancer; 2019 Apr; 10(4):1001-1004. PubMed ID: 30810271
[TBL] [Abstract][Full Text] [Related]
47. Limbic encephalitis and small cell lung cancer. Clinical and immunological features.
Alamowitch S; Graus F; Uchuya M; Reñé R; Bescansa E; Delattre JY
Brain; 1997 Jun; 120 ( Pt 6)():923-8. PubMed ID: 9217677
[TBL] [Abstract][Full Text] [Related]
48. Paraneoplastic neurological syndrome and polyglandular autoimmune syndrome type 2 in a case of small cell lung cancer.
Watanabe S; Tanaka J; Ohta T; Yoshizawa H; Gejyo F
Thorax; 2008 Dec; 63(12):1118-9. PubMed ID: 19020277
[TBL] [Abstract][Full Text] [Related]
49. Expanding the spectrum of SOX1-antibodies in neuropathy: the coexistence of anti-SOX1 and Guillain-Barré syndrome-a case report.
Coniglio S; Turchi G; Giovannini G; Mazzoli M; Meletti S; Vaudano AE
Neurol Sci; 2022 Jun; 43(6):3979-3982. PubMed ID: 35391602
[TBL] [Abstract][Full Text] [Related]
50. Focal paraneoplastic limbic encephalitis presenting as orgasmic epilepsy.
Fadul CE; Stommel EW; Dragnev KH; Eskey CJ; Dalmau JO
J Neurooncol; 2005 Apr; 72(2):195-8. PubMed ID: 15926002
[TBL] [Abstract][Full Text] [Related]
51. Imbalances in circulating lymphocyte subsets in Hu antibody associated paraneoplastic neurological syndromes.
de Beukelaar JW; Sillevis Smitt PA; Hop WC; Kraan J; Hooijkaas H; Verjans GM; Gratama JW
Eur J Neurol; 2007 Dec; 14(12):1383-91. PubMed ID: 18028190
[TBL] [Abstract][Full Text] [Related]
52. Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings.
Masangkay N; Basu S; Moghbel M; Kwee T; Alavi A
Nucl Med Commun; 2014 Oct; 35(10):1038-46. PubMed ID: 25023997
[TBL] [Abstract][Full Text] [Related]
53. Paraneoplastic neurological syndromes (PNS) caused by occult breast cancer and metastatic carcinoma of the lymph node.
Gong J; Zhang Y; Huang Y; Yin W; Zhang W; Feng J; Wang S; Wu X
Eur J Gynaecol Oncol; 2015; 36(4):485-7. PubMed ID: 26390710
[TBL] [Abstract][Full Text] [Related]
54. [Clinical characteristics of "classical" and "non-classical" paraneoplastic neurological syndrome].
Lyu XY; Wang GP; Tang QQ; Cheng ZZ; Gui W; Tian YH
Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(9):615-619. PubMed ID: 33685041
[No Abstract] [Full Text] [Related]
55. Autoimmune response in lung cancer patients with neurological paraneoplastic syndromes.
Michalak S; Piorunek T; Zaborowski M; Rybacka-Mossakowska J; Stefens-Stawna P; Kalinowska-Łyszczarz A; Kozubski W; Batura-Gabryel H
Neurol Neurochir Pol; 2019; 53(3):217-226. PubMed ID: 31187476
[TBL] [Abstract][Full Text] [Related]
56. Neurological paraneoplastic syndrome caused by small cell lung cancer: a case report.
Yan W; Wang X; Wang Y; Liu L
Transl Cancer Res; 2020 Apr; 9(4):2999-3002. PubMed ID: 35117656
[TBL] [Abstract][Full Text] [Related]
57. The use of eye-movement recording in patients with anti-Hu antibody-associated paraneoplastic neurological syndromes to objectively determine extent and course of disease.
Janssen M; van Broekhoven F; Sillevis Smitt P; Frens M; van der Geest J
Eur J Neurol; 2021 Jun; 28(6):2126-2132. PubMed ID: 33675135
[TBL] [Abstract][Full Text] [Related]
58. Chorea and related movement disorders of paraneoplastic origin: the PNS EuroNetwork experience.
Vigliani MC; Honnorat J; Antoine JC; Vitaliani R; Giometto B; Psimaras D; Franchino F; Rossi C; Graus F;
J Neurol; 2011 Nov; 258(11):2058-68. PubMed ID: 21559939
[TBL] [Abstract][Full Text] [Related]
59. Caveats and Pitfalls of SOX1 Autoantibody Testing With a Commercial Line Blot Assay in Paraneoplastic Neurological Investigations.
Ruiz-García R; Martínez-Hernández E; García-Ormaechea M; Español-Rego M; Sabater L; Querol L; Illa I; Dalmau J; Graus F
Front Immunol; 2019; 10():769. PubMed ID: 31031763
[TBL] [Abstract][Full Text] [Related]
60. Disturbance in the serum IgG subclass distribution in patients with anti-Hu positive paraneoplastic neurological syndromes.
Blaes F; Klotz M; Funke D; Strittmatter M; Kraus J; Kaps M
Eur J Neurol; 2002 Jul; 9(4):369-72. PubMed ID: 12099920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
